COVID-19

Coronavirus disease 2019 (COVID-19) is an infectious respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The disease was first identified in Wuhan, China in late 2019 and rapidly spread internationally. The virus belongs to the coronavirus family, which includes several strains known to cause respiratory infections ranging from the common cold to more severe diseases such as SARS and MERS.

COVID-19 symptoms typically appear 1 to 14 days after exposure and commonly include fever, fatigue, cough, breathing difficulties, loss of smell, and loss of taste. The clinical course varies considerably: approximately 81% of symptomatic patients develop mild to moderate disease, 14% progress to severe symptoms involving dyspnea, hypoxia, or significant lung involvement, and 5% develop critical illness characterized by respiratory failure, shock, or multiorgan dysfunction. Complications may include pneumonia, acute respiratory distress syndrome, cardiovascular events such as thrombosis and heart inflammation, neurologic manifestations, and liver enzyme elevations. A notable proportion of survivors experience persistent symptoms lasting months or years, a condition termed long COVID, characterized by fatigue, cognitive dysfunction, and shortness of breath.

COVID-19 originated in Wuhan, China in late 2019 and spread worldwide beginning in January 2020, resulting in the first coronavirus pandemic. The disease has affected virtually all countries, with hundreds of millions of confirmed cases reported globally. Surveillance systems have tracked case counts, hospitalizations, deaths, and more recently, variant emergence and population immunity levels. The declaration of the end of the global health emergency in May 2023 marked a transition toward sustained disease management rather than acute emergency response.

COVID-19 spreads primarily through inhalation of virus-containing respiratory droplets and aerosols emitted by infected individuals during breathing, talking, coughing, sneezing, or singing. Transmission can also occur when infectious particles contact the eyes, nose, or mouth. The risk of transmission is highest during close proximity to an infected person, though airborne transmission over longer distances can occur, particularly in indoor settings with poor ventilation.

Older adults face substantially elevated risk of severe COVID-19 outcomes and mortality compared to younger populations. Individuals with certain underlying health conditions, including cardiovascular disease, diabetes, chronic respiratory disease, and immunocompromised states, also demonstrate higher risk of severe disease. The interaction between age and comorbidities significantly influences clinical prognosis.

Prevention measures have included vaccination to reduce infection severity and transmission, mask-wearing to limit respiratory droplet spread, physical distancing to reduce close-contact exposure, and improved ventilation in indoor spaces to dilute airborne viral particles. Public health guidance has evolved throughout the pandemic as evidence accumulated regarding transmission dynamics and vaccine effectiveness.

Surveillance for COVID-19 has utilized multiple data streams including confirmed case counts, positivity rates, hospitalizations, intensive care admissions, mortality figures, and genomic sequencing for variant tracking. Interpretation of case data requires consideration of changes in testing practices, reporting delays, and the proportion of asymptomatic or mildly symptomatic infections that may go undetected. Post-emergency surveillance emphasizes monitoring trends in severe outcomes and variant evolution rather than comprehensive case enumeration.

1. 1 Wikidata. COVID-19.
2. 2 Wikipedia. COVID-19 - Wikipedia.

ICD-10

U07.1

ICD-11

RA01

Total cases

18.1M

Total deaths

4K

Peak month

2022-01

Coverage

3 reporting countries · 2000-01-01 → 2026-05-02